[Esmaloride--a new potassium neutral diuretic combination. Clinical pharmacologic properties].
D000450:Aldosterone / Q000097:blood; D000584:Amiloride / Q000627:therapeutic use*; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D003404:Creatinine / Q000097:blood; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D011188:Potassium / Q000097:blood*; D011719:Pyrazines / Q000627:therapeutic use*; D014237:Trichlormethiazide / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood; D014527:Uric Acid / Q000097:blood; D014882:Water-Electrolyte Balance / Q000187:drug effects
D001786:Blood Glucose; D004338:Drug Combinations; D011719:Pyrazines; D014280:Triglycerides; C044677:Esmalorid; D014527:Uric Acid; D000450:Aldosterone; D000584:Amiloride; D003404:Creatinine; D014237:Trichlormethiazide; D011188:Potassium
Esmalorid--eine neue Kalium-neutrale Diuretikakombination. Klinisch-pharmakologische Eigenschaften.